- Promoting Ethical Payment in Human Infection Challenge Studies.Holly Fernandez Lynch, Thomas C. Darton, Jae Levy, Frank McCormick, Ubaka Ogbogu, Ruth O. Payne, Alvin E. Roth, Akilah Jefferson Shah, Thomas Smiley & Emily A. Largent - 2021 - American Journal of Bioethics 21 (3):11-31.details
|
|
Risk, benefit, and social value in Covid-19 human challenge studies: pandemic decision making in historical context.Mabel Rosenheck - 2022 - Monash Bioethics Review 40 (2):188-213.details
|
|
SARS-CoV-2 challenge studies: ethics and risk minimisation.Susan Bull, Euzebiusz Jamrozik, Ariella Binik & Michael J. Parker - 2021 - Journal of Medical Ethics 47 (12):e79-e79.details
|
|
Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.Robert Steel, Lara Buchak & Nir Eyal - 2020 - Journal of Medical Ethics 46 (12):808-812.details
|
|
Conducting Controlled human infection model studies in India is an ethical obligation.Saumil Dholakia & S. Y. Dholakia - 2018 - Indian Journal of Medical Ethics 3 (4).details
|
|
Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia.Søren Holm - 2020 - Journal of Medical Ethics 46 (9):569-573.details
|
|
Stakeholder views on the acceptability of human infection studies in Malawi.Kate Gooding, Stephen B. Gordon, Michael Parker, Rodrick Sambakunsi, Markus Gmeiner, Jamie Rylance, Kondwani Jambo & Blessings M. Kapumba - 2020 - BMC Medical Ethics 21 (1):1-15.details
|
|
COVID-19 human challenge trials and randomized controlled trials: lessons for the next pandemic.Charles Weijer - 2024 - Research Ethics 20 (4):636-649.details
|
|
Good reasons to vaccinate: mandatory or payment for risk?Julian Savulescu - 2021 - Journal of Medical Ethics 47 (2):78-85.details
|
|
Payment in challenge studies: ethics, attitudes and a new payment for risk model.Olivia Grimwade, Julian Savulescu, Alberto Giubilini, Justin Oakley, Joshua Osowicki, Andrew J. Pollard & Anne-Marie Nussberger - 2020 - Journal of Medical Ethics 46 (12):815-826.details
|
|
Coronavirus Human Infection Challenge Studies: Assessing Potential Benefits and Risks.Euzebiusz Jamrozik, George S. Heriot & Michael J. Selgelid - 2020 - Journal of Bioethical Inquiry 17 (4):709-715.details
|
|
Reshaping consent so we might improve participant choice (III) – How is the research participant’s understanding currently checked and how might we improve this process?Hugh Davies, Simon E. Kolstoe & Anthony Lockett - 2024 - Research Ethics 20 (3):604-612.details
|
|
Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using Schistosoma mansoni in Uganda.Moses Egesa, Agnes Ssali, Edward Tumwesige, Moses Kizza, Emmanuella Driciru, Fiona Luboga, Meta Roestenberg, Janet Seeley & Alison M. Elliott - 2022 - Global Bioethics 33 (1):78-102.details
|
|
Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy.Euzebiusz Jamrozik & Michael J. Selgelid - 2020 - Journal of Medical Ethics 46 (9):601-609.details
|
|
Back to WHAT? The role of research ethics in pandemic times.Jan Helge Solbakk, Heidi Beate Bentzen, Søren Holm, Anne Kari Tolo Heggestad, Bjørn Hofmann, Annette Robertsen, Anne Hambro Alnæs, Shereen Cox, Reidar Pedersen & Rose Bernabe - 2021 - Medicine, Health Care and Philosophy 24 (1):3-20.details
|
|
Ethics, health policy, and Zika: From emergency to global epidemic?Euzebiusz Jamrozik & Michael J. Selgelid - 2018 - Journal of Medical Ethics 44 (5):343-348.details
|
|
How to hold an ethical pox party.Euzebiusz Jamrozik - 2017 - Journal of Medical Ethics 44 (4):257-261.details
|
|